Publikationsrepositorium - Helmholtz-Zentrum Dresden-Rossendorf

Using the novel universal CAR platform technology “UniCAR” to target tumors overexpressing disialoganglioside (GD2)

Mitwasi, N.; Feldmann, A.; Bergmann, R.; Rössig, C.; Bachmann, M.

Keywords: CAR Technology; UniCAR T cells; GD2

• Vortrag (Konferenzbeitrag)
  47th Annual Meeting of the German Society for Immunology, 12.09.2017, Erlangen, Germany

Permalink: https://www.hzdr.de/publications/Publ-26057